Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan A Grupp

Showing results (111-120 of 238) with videos related to

Pageof 24
Sort By:
Blood|June 12, 2008
mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemiaDavid T Teachey, Cecilia Sheen, Junior Hall, et al.
Molecular and Cellular Biology|August 17, 2022
Correction for Bagashev et al., "CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic Reticulum"Asen Bagashev, Elena Sotillo, Chih-Hang Anthony Tang, et al.
Blood|April 12, 2015
IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patientsMichael A Pulsipher, Chris Carlson, Bryan Langholz, et al.
British Journal of Haematology|February 12, 2009
Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndromeDavid T Teachey, Robert Greiner, Alix Seif, et al.
The Lancet. Haematology|March 31, 2023
Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trialStephan A Grupp, Selim Corbacioglu, Hyoung Jin Kang, et al.
British Journal of Haematology|April 27, 2017
Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantationPaul G Richardson, Angela R Smith, Brandon M Triplett, et al.
Blood Advances|January 26, 2021
Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapyJochen Buechner, Stephan A Grupp, Hidefumi Hiramatsu, et al.
Blood|March 2, 2017
Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemiaSarah K Tasian, Saad S Kenderian, Feng Shen, et al.
Cell Discovery|November 28, 2018
A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine releaseYiyang Xu, Zhiyuan Yang, Lucas H Horan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
Interferon-gamma-dependent infiltration of human T cells into neuroblastoma tumors in vivoGregor S D Reid, Xiaochuan Shan, Christina M Coughlin, et al.
Pageof 24

Showing results (111-120 of 238) with videos related to

Sort By:
Pageof 24
Blood|June 12, 2008
mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemiaDavid T Teachey, Cecilia Sheen, Junior Hall, et al.
Molecular and Cellular Biology|August 17, 2022
Correction for Bagashev et al., "CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic Reticulum"Asen Bagashev, Elena Sotillo, Chih-Hang Anthony Tang, et al.
Blood|April 12, 2015
IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patientsMichael A Pulsipher, Chris Carlson, Bryan Langholz, et al.
British Journal of Haematology|February 12, 2009
Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndromeDavid T Teachey, Robert Greiner, Alix Seif, et al.
The Lancet. Haematology|March 31, 2023
Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trialStephan A Grupp, Selim Corbacioglu, Hyoung Jin Kang, et al.
British Journal of Haematology|April 27, 2017
Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantationPaul G Richardson, Angela R Smith, Brandon M Triplett, et al.
Blood Advances|January 26, 2021
Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapyJochen Buechner, Stephan A Grupp, Hidefumi Hiramatsu, et al.
Blood|March 2, 2017
Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemiaSarah K Tasian, Saad S Kenderian, Feng Shen, et al.
Cell Discovery|November 28, 2018
A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine releaseYiyang Xu, Zhiyuan Yang, Lucas H Horan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
Interferon-gamma-dependent infiltration of human T cells into neuroblastoma tumors in vivoGregor S D Reid, Xiaochuan Shan, Christina M Coughlin, et al.
Pageof 24